Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
Public ClinicalTrials.gov record NCT05020860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial to Correlate Early Clinical Response to Pathologic Outcome With Neoadjuvant Systemic Therapy in Patients With Early Stage Breast Cancer
Study identification
- NCT ID
- NCT05020860
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Baylor Breast Care Center
- Other
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Interventions
- Carboplatin Drug
- Cyclophosphamide Drug
- Doxorubicin Drug
- Paclitaxel Drug
- Pembrolizumab Drug
- Pertuzumab Drug
- Pertuzumab/Trastuzumab/Hyaluronidase-zzxf Drug
- Trastuzumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 17, 2023
- Primary completion
- Jul 31, 2027
- Completion
- Oct 31, 2029
- Last update posted
- Feb 26, 2025
2023 – 2029
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Harris Health System - Smith Clinic | Houston | Texas | 77054 | Recruiting |
| O'Quinn Medical Tower - McNair Campus - Dan L Duncan Comprehensive Cancer Center | Houston | Texas | 77054 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05020860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2025 · Synced May 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05020860 live on ClinicalTrials.gov.